WEBVTT - Hope, panic and a brain tumour 

0:00:04.040 --> 0:00:06.920
<v Speaker 1>From The Australian. Here's what's on the front. I'm Claire Harvey.

0:00:06.960 --> 0:00:14.400
<v Speaker 1>It's Friday, November fifteenth. Australia must move faster to test

0:00:14.560 --> 0:00:19.320
<v Speaker 1>DNA driven treatments and then make genomic personalized medicine part

0:00:19.360 --> 0:00:22.520
<v Speaker 1>of healthcare at every level. That's the plea for a

0:00:22.560 --> 0:00:27.520
<v Speaker 1>health revolution from the nation's top scientists, doctors and patients,

0:00:27.840 --> 0:00:34.800
<v Speaker 1>revealed today at The Australian dot com dot au. Today

0:00:34.800 --> 0:00:38.280
<v Speaker 1>we're launching a big new frontier for our journalism, deep

0:00:38.400 --> 0:00:42.560
<v Speaker 1>coverage of health, from the latest research breakthroughs to practical

0:00:42.600 --> 0:00:48.160
<v Speaker 1>advice on everything from exercise to menopause, and deeply personal

0:00:48.200 --> 0:00:53.960
<v Speaker 1>stories like the one we're about to share. One of

0:00:54.000 --> 0:00:58.680
<v Speaker 1>the most inspiring Australians around is Richard Scolier, the cancer

0:00:58.720 --> 0:01:02.480
<v Speaker 1>professor who's turned his own brain tumor into a real

0:01:02.560 --> 0:01:07.880
<v Speaker 1>time experiment in survival. The Australian's senior journalist, Tanzy Harcourt

0:01:08.120 --> 0:01:11.240
<v Speaker 1>has spent the past thirteen years living with a brain

0:01:11.280 --> 0:01:15.760
<v Speaker 1>tumor diagnosis of her own, and today we hear how

0:01:15.840 --> 0:01:19.720
<v Speaker 1>patients like Tansy are responding to what they're calling the

0:01:19.800 --> 0:01:30.440
<v Speaker 1>Scholiar effect. For the people in Australia, living with brain tumors.

0:01:30.640 --> 0:01:32.440
<v Speaker 1>This was massive news.

0:01:33.360 --> 0:01:38.000
<v Speaker 2>Professor Richard Scolia has saved thousands from a certain death sentence,

0:01:38.800 --> 0:01:42.000
<v Speaker 2>yet he's just been handed his own. The world's leading

0:01:42.040 --> 0:01:45.840
<v Speaker 2>melanoma pathologist has incurable brain cancer.

0:01:47.240 --> 0:01:51.000
<v Speaker 1>Glioblastoma is a rare and aggressive type of brain tumor

0:01:51.280 --> 0:01:56.520
<v Speaker 1>that ravages tissue with devastating efficiency. All new cases are

0:01:56.560 --> 0:02:03.360
<v Speaker 1>automatically classified as Grade four, with no exceptions. Richard Scolia

0:02:03.520 --> 0:02:06.680
<v Speaker 1>was named joint Australian of the Year for twenty twenty four.

0:02:07.080 --> 0:02:12.240
<v Speaker 1>Alongside his friend and colleague, Professor Georgina Long. They've dedicated

0:02:12.280 --> 0:02:17.000
<v Speaker 1>their careers to fighting another type of cancer, melanoma. Moving

0:02:17.120 --> 0:02:21.359
<v Speaker 1>swiftly past the initial shock of Richard's diagnosis, the pair

0:02:21.480 --> 0:02:26.880
<v Speaker 1>channeled their expertise in immunotherapy into a world first treatment regime,

0:02:27.280 --> 0:02:32.000
<v Speaker 1>with Scolia as the self described guinea pig. The big

0:02:32.040 --> 0:02:36.079
<v Speaker 1>idea was to give immunotherapy before having surgery to remove

0:02:36.120 --> 0:02:43.320
<v Speaker 1>the tumor, something that has been shown to work with melanoma.

0:02:41.520 --> 0:02:45.400
<v Speaker 3>And so this idea of giving immunotherapy before my tumor

0:02:45.520 --> 0:02:49.359
<v Speaker 3>was debolked made total sense to me. So never been

0:02:49.440 --> 0:02:53.079
<v Speaker 3>tried before with combination in minotherapy, but for me. It

0:02:53.120 --> 0:02:55.120
<v Speaker 3>felt like the right thing to do. Give it a crack,

0:02:55.200 --> 0:02:57.880
<v Speaker 3>see if we can make a difference in the work.

0:02:58.280 --> 0:03:01.359
<v Speaker 3>I've learned some science that were see if this is

0:03:01.400 --> 0:03:02.720
<v Speaker 3>something worth exploring.

0:03:04.760 --> 0:03:08.720
<v Speaker 1>Just like a vaccine, immunotherapy uses the body's own defenses

0:03:09.080 --> 0:03:13.560
<v Speaker 1>to destroy cancer cells. Scholia is receiving the therapy in

0:03:13.639 --> 0:03:18.280
<v Speaker 1>conjunction with conventional cancer treatment, and so far the results

0:03:18.320 --> 0:03:22.560
<v Speaker 1>are promising. After a year, Scholia's MRI scans show no

0:03:22.720 --> 0:03:26.239
<v Speaker 1>recurrence of the tumor. He's speaking here with Network seven.

0:03:26.960 --> 0:03:29.800
<v Speaker 3>I think it's amazing I'm still here, But it could

0:03:29.840 --> 0:03:33.200
<v Speaker 3>just be luck that I'm only one patient, and some

0:03:33.360 --> 0:03:36.680
<v Speaker 3>patients do survive for a long time in brain cancer.

0:03:37.040 --> 0:03:40.960
<v Speaker 3>So ultimately we need a clinical trial that puts patients

0:03:41.000 --> 0:03:44.200
<v Speaker 3>into different groups to see if this treatment actually works

0:03:44.280 --> 0:03:46.280
<v Speaker 3>or not. Is it just a fluke that I happen

0:03:46.360 --> 0:03:48.720
<v Speaker 3>to be alive, not related to the treatment.

0:03:50.600 --> 0:03:54.120
<v Speaker 1>Tanzy Harcourt is a business journalist with The Australian, and

0:03:54.200 --> 0:03:58.400
<v Speaker 1>she remembers vividly hearing the news of Richard Schollier's diagnosis.

0:03:59.640 --> 0:04:03.200
<v Speaker 4>When was diagnosed, I had a lot of people contacting

0:04:03.240 --> 0:04:06.240
<v Speaker 4>me just because I have a brain tumor. Myself I

0:04:06.320 --> 0:04:09.200
<v Speaker 4>was diagnosed thirteen years ago now, and I don't have

0:04:09.240 --> 0:04:12.600
<v Speaker 4>a glioblastoma. I have something that at the time was

0:04:12.640 --> 0:04:16.560
<v Speaker 4>called an oligo astrocytoma. People reached out to me because

0:04:16.760 --> 0:04:20.520
<v Speaker 4>anyone with a malignant brain tumor faces an uphill battle.

0:04:20.560 --> 0:04:26.120
<v Speaker 4>There's been very little developments in finding a qure for

0:04:26.520 --> 0:04:29.880
<v Speaker 4>brain tumors, and he was just so public with what

0:04:29.920 --> 0:04:32.000
<v Speaker 4>he was trying to do, which is something different to

0:04:32.040 --> 0:04:33.840
<v Speaker 4>what has been done in the past.

0:04:34.480 --> 0:04:37.600
<v Speaker 1>Richard Scolia and his professional partner, Georgina Long are experts

0:04:37.640 --> 0:04:40.840
<v Speaker 1>in melanoma and have pioneered amazing treatments for that kind

0:04:40.880 --> 0:04:44.360
<v Speaker 1>of cancer. This was something new to them. How did

0:04:44.360 --> 0:04:47.080
<v Speaker 1>they apply the lessons that they've learned in melanoma treatment

0:04:47.200 --> 0:04:49.600
<v Speaker 1>to this globlastoma that Richard was facing.

0:04:49.920 --> 0:04:52.039
<v Speaker 4>There's a couple of things that they're doing that is

0:04:52.080 --> 0:04:55.840
<v Speaker 4>a little bit different. The first, really significant thing is

0:04:55.920 --> 0:04:59.880
<v Speaker 4>that he was treated before his surgery. Now, the reason

0:05:00.040 --> 0:05:02.960
<v Speaker 4>why that is unusual in brain tumors is because most people,

0:05:02.960 --> 0:05:06.120
<v Speaker 4>if they have a brain tumor, they've got pressure on

0:05:06.160 --> 0:05:07.800
<v Speaker 4>the brain as a result of that, and so to

0:05:07.880 --> 0:05:11.400
<v Speaker 4>reduce the pressure they need a surgery. So the surgery

0:05:11.560 --> 0:05:13.679
<v Speaker 4>then is how they diagnose what kind of brain tumor

0:05:13.680 --> 0:05:15.960
<v Speaker 4>it is. But it's also taking pressure off the brain,

0:05:16.040 --> 0:05:19.000
<v Speaker 4>which can be fatal. So in his case, he had

0:05:19.040 --> 0:05:22.320
<v Speaker 4>a seizure when he was overseas and it wasn't putting

0:05:22.400 --> 0:05:24.520
<v Speaker 4>so much pressure on that he needed to be operated

0:05:24.520 --> 0:05:28.120
<v Speaker 4>on immediately. He was able to return to Australia and then,

0:05:28.200 --> 0:05:31.720
<v Speaker 4>of course, because he's an expert in that field, they

0:05:31.720 --> 0:05:34.440
<v Speaker 4>were able to come up with a new treatment protocol

0:05:34.480 --> 0:05:38.200
<v Speaker 4>for him, give him that first and then have the surgery.

0:05:38.720 --> 0:05:42.480
<v Speaker 4>That's an unusual step and that's not something that is

0:05:42.680 --> 0:05:45.880
<v Speaker 4>currently in clinical trials in Australia, I think maybe even

0:05:45.920 --> 0:05:46.760
<v Speaker 4>anywhere in the world.

0:05:50.240 --> 0:05:54.240
<v Speaker 1>He's had a year of no reappearance of his globelastoma.

0:05:55.080 --> 0:05:57.720
<v Speaker 1>That is wonderful news for Richard and his family, of course,

0:05:57.800 --> 0:06:01.679
<v Speaker 1>but it's caused some mixed feeling among experts and also

0:06:01.800 --> 0:06:04.600
<v Speaker 1>other people who are living with cancer. Can you talk

0:06:04.640 --> 0:06:07.240
<v Speaker 1>a little bit about that. Why is that causing mixed feelings?

0:06:07.520 --> 0:06:10.800
<v Speaker 4>It's causing mixed feelings because or to start with, anyone

0:06:10.839 --> 0:06:14.119
<v Speaker 4>that's dealing with the glier blastomer has a very bleak

0:06:14.720 --> 0:06:19.520
<v Speaker 4>future under the current treatment protocols. So the idea of

0:06:19.720 --> 0:06:22.359
<v Speaker 4>somebody that is so highly regarded coming up with a

0:06:22.440 --> 0:06:26.120
<v Speaker 4>new idea and then being so public about it is

0:06:26.160 --> 0:06:30.160
<v Speaker 4>creating an incredible amount of hope in the community, which

0:06:30.200 --> 0:06:33.320
<v Speaker 4>is understandable. And the only problem with that, of course,

0:06:33.480 --> 0:06:38.920
<v Speaker 4>is that one year doesn't necessarily indicate anything one way

0:06:39.000 --> 0:06:42.280
<v Speaker 4>or another. It could be that this treatment protocol is working,

0:06:43.160 --> 0:06:47.359
<v Speaker 4>or it could be he had a really good reception,

0:06:47.480 --> 0:06:50.320
<v Speaker 4>which means the surgery went really well. It could be

0:06:50.360 --> 0:06:53.960
<v Speaker 4>the radiotherapy, or it might not work at all. It's

0:06:53.960 --> 0:06:57.120
<v Speaker 4>actually just too early to tell, and he is clear

0:06:57.160 --> 0:06:59.520
<v Speaker 4>about that in his book. He's clear about the fact

0:06:59.520 --> 0:07:02.400
<v Speaker 4>that it's too early to tell. But every time he

0:07:02.480 --> 0:07:05.200
<v Speaker 4>expresses hope and relief when he has a good result,

0:07:05.320 --> 0:07:09.640
<v Speaker 4>and still there's just an outpouring of people that then

0:07:09.720 --> 0:07:11.800
<v Speaker 4>want to do that as well for obvious reasons.

0:07:13.280 --> 0:07:17.040
<v Speaker 1>Is there an equity issue here too, where people may feel,

0:07:17.080 --> 0:07:19.800
<v Speaker 1>if they are suffering something similar to Richard, for example,

0:07:20.080 --> 0:07:22.240
<v Speaker 1>that they're not getting the same opportunities that he is,

0:07:22.320 --> 0:07:24.960
<v Speaker 1>and if they are feeling like that, is that valid.

0:07:25.400 --> 0:07:27.080
<v Speaker 4>I think that there are a lot of people that

0:07:27.120 --> 0:07:30.120
<v Speaker 4>are feeling like that. I've got two neuroncologists and one

0:07:30.200 --> 0:07:34.600
<v Speaker 4>of them is also a Richard's neurooncologist, And I know

0:07:34.720 --> 0:07:37.760
<v Speaker 4>that there's a lot of people that have been reaching

0:07:37.800 --> 0:07:40.520
<v Speaker 4>out to their various specialists saying, we want to do

0:07:40.600 --> 0:07:42.800
<v Speaker 4>that treatment, and they've even been reaching out to the

0:07:42.800 --> 0:07:45.680
<v Speaker 4>Melanoma Institute of Australia, who's had to put something up

0:07:45.720 --> 0:07:49.200
<v Speaker 4>saying we don't treat brain tumors. So I think that

0:07:49.320 --> 0:07:52.080
<v Speaker 4>people are perhaps feeling a bit panic that they're missing out,

0:07:52.640 --> 0:07:55.520
<v Speaker 4>But the truth is that the various professionals need to

0:07:55.560 --> 0:07:58.440
<v Speaker 4>have time to try and create a clinical trial that

0:07:58.520 --> 0:08:03.160
<v Speaker 4>replicates the work that Richard and Georgina Long have done.

0:08:03.280 --> 0:08:05.960
<v Speaker 4>So they're producing a paper themselves and there are I

0:08:06.000 --> 0:08:10.760
<v Speaker 4>think multiple processes underway at the moment where various specialists

0:08:10.760 --> 0:08:14.000
<v Speaker 4>for neurooncology are trying to create a clinical trial, but

0:08:14.200 --> 0:08:16.240
<v Speaker 4>you can't just kind of jump into it because obviously

0:08:16.760 --> 0:08:19.440
<v Speaker 4>they're very risky and dangerous. And one of the issues

0:08:19.440 --> 0:08:22.200
<v Speaker 4>with any of these things is that you can get

0:08:22.240 --> 0:08:24.440
<v Speaker 4>pressure on the brain as a result of the drugs

0:08:24.440 --> 0:08:27.560
<v Speaker 4>that you're taking. So it's not the same as perhaps

0:08:27.640 --> 0:08:30.000
<v Speaker 4>if you had a cancer somewhere else in your body

0:08:30.000 --> 0:08:34.760
<v Speaker 4>and it swelled as a result of immunotherapy that wouldn't

0:08:34.800 --> 0:08:39.120
<v Speaker 4>necessarily have as diret consequences as if it was inside

0:08:39.160 --> 0:08:40.920
<v Speaker 4>the confined space of your skull.

0:08:45.280 --> 0:08:49.280
<v Speaker 1>Coming up, what's the balance between fear and hope when

0:08:49.320 --> 0:08:52.520
<v Speaker 1>a story as big as Richard's school years comes along.

0:08:53.559 --> 0:08:56.319
<v Speaker 1>This is just a taste of The Australian's new foray

0:08:56.400 --> 0:08:59.400
<v Speaker 1>into deep coverage of health. Check it out at the

0:08:59.440 --> 0:09:02.760
<v Speaker 1>Australian dot com dot au and we'll be back after

0:09:02.800 --> 0:09:19.680
<v Speaker 1>the break. At The Australian, Tansy works for our Business

0:09:19.720 --> 0:09:24.200
<v Speaker 1>section as a senior journalist. She grills CEOs and CFOs

0:09:24.240 --> 0:09:27.760
<v Speaker 1>about profits and balance sheets and corporate decision making, so

0:09:27.800 --> 0:09:32.080
<v Speaker 1>she's very comfortable with charts and graphs, the numbers that

0:09:32.200 --> 0:09:35.440
<v Speaker 1>tell us a bigger story that's informed the way she's

0:09:35.440 --> 0:09:40.040
<v Speaker 1>approached cancer as a story and as a human experience.

0:09:41.280 --> 0:09:44.360
<v Speaker 4>Look, I think I probably pestered my doctors more than

0:09:44.360 --> 0:09:45.960
<v Speaker 4>they would like, because every time I go in for

0:09:46.040 --> 0:09:49.240
<v Speaker 4>my six monthly scans, I always have questions. There might

0:09:49.280 --> 0:09:51.720
<v Speaker 4>be one trial that's been tried here and something else

0:09:51.760 --> 0:09:54.240
<v Speaker 4>that's come up there, and I always like to ask

0:09:54.760 --> 0:09:59.040
<v Speaker 4>the statistics are pretty bad, and the treatment protocols haven't

0:09:59.120 --> 0:10:01.280
<v Speaker 4>changed all that much either at this point in time.

0:10:01.520 --> 0:10:05.920
<v Speaker 4>Right now, the best treatment is a really good brain surgery.

0:10:06.000 --> 0:10:11.240
<v Speaker 4>I've had two, a really good resection it's called and radiotherapy.

0:10:11.400 --> 0:10:14.600
<v Speaker 4>So there are chemotherapy drugs, but they generally at this

0:10:14.640 --> 0:10:18.199
<v Speaker 4>point in time, are more helping in terms of quality

0:10:18.240 --> 0:10:22.120
<v Speaker 4>of life rather than extending life.

0:10:25.320 --> 0:10:26.920
<v Speaker 1>They talk about the school your effect.

0:10:27.200 --> 0:10:28.240
<v Speaker 2>What is that?

0:10:28.240 --> 0:10:32.000
<v Speaker 4>That's basically this idea and you alluded to it earlier

0:10:32.000 --> 0:10:35.720
<v Speaker 4>that people want to have what he's doing because the

0:10:35.760 --> 0:10:39.600
<v Speaker 4>work that he's done in Melanomahi and Georgina. Obviously that's

0:10:39.640 --> 0:10:42.080
<v Speaker 4>the reason why they were the Australians of the Year.

0:10:42.120 --> 0:10:44.920
<v Speaker 4>This year has been so exciting and everyone thinks, well,

0:10:44.920 --> 0:10:49.040
<v Speaker 4>if he's doing it, then it must be right, and

0:10:49.440 --> 0:10:52.280
<v Speaker 4>hopefully he will be right. But it's just too early

0:10:52.440 --> 0:10:55.240
<v Speaker 4>to tell that yet. So I think everyone kind of

0:10:55.440 --> 0:10:58.800
<v Speaker 4>hopes and crosses their fingers. But you can't have everyone

0:10:58.880 --> 0:11:02.199
<v Speaker 4>jumping into what he's doing at this point in time.

0:11:02.679 --> 0:11:05.160
<v Speaker 1>Yeah. So at the same time, here we have this

0:11:05.360 --> 0:11:08.680
<v Speaker 1>beacon of hope for many people, and we also have

0:11:08.760 --> 0:11:11.520
<v Speaker 1>frustration and maybe a bit of panic. As you said,

0:11:12.760 --> 0:11:14.920
<v Speaker 1>how do you think ultimately we'll look back at the

0:11:14.920 --> 0:11:18.440
<v Speaker 1>balance of those two things. Is this a moment where

0:11:18.679 --> 0:11:22.280
<v Speaker 1>we take a big leap forward or is it a

0:11:22.280 --> 0:11:23.560
<v Speaker 1>lot of pain for a lot of people.

0:11:26.040 --> 0:11:29.040
<v Speaker 4>My suspicion is that it will be both. I think

0:11:29.040 --> 0:11:33.160
<v Speaker 4>immunotherapy has so far proven to be the main area

0:11:33.240 --> 0:11:37.840
<v Speaker 4>where there are breakthroughs in cancer treatments, So I think

0:11:37.880 --> 0:11:41.160
<v Speaker 4>that hope is important, and I think it's pretty likely

0:11:41.200 --> 0:11:44.360
<v Speaker 4>that he's on the right track. But whether or not

0:11:44.400 --> 0:11:46.800
<v Speaker 4>it's going to be soon enough for him or anyone

0:11:46.840 --> 0:11:50.520
<v Speaker 4>that's even currently diagnosed, I don't know. The other thing

0:11:50.520 --> 0:11:53.120
<v Speaker 4>that I think is really important to draw attention to

0:11:53.280 --> 0:11:55.800
<v Speaker 4>is just the fact that he's done such a good

0:11:56.040 --> 0:11:59.800
<v Speaker 4>job of talking about his story that it's raising a

0:11:59.800 --> 0:12:03.720
<v Speaker 4>w farness of brain tumors, and that in turn helps

0:12:04.040 --> 0:12:07.040
<v Speaker 4>raise money for research into brain tumors because it's quite

0:12:07.040 --> 0:12:10.360
<v Speaker 4>an expensive business. There is that mixture of hope and

0:12:10.480 --> 0:12:14.280
<v Speaker 4>possibly disappointment and anxiety for everyone, but hopefully he's going

0:12:14.320 --> 0:12:18.280
<v Speaker 4>to nail it first go well.

0:12:18.280 --> 0:12:19.520
<v Speaker 1>Thank you for sharing your story.

0:12:19.960 --> 0:12:20.320
<v Speaker 4>Thank you.

0:12:23.160 --> 0:12:26.080
<v Speaker 1>Tanzy Harcourt is a senior reporter with The Australian. You

0:12:26.120 --> 0:12:29.200
<v Speaker 1>can read her story at The Australian dot com dot

0:12:29.200 --> 0:12:39.400
<v Speaker 1>a U. Thanks for joining us this week. On the front.

0:12:39.480 --> 0:12:42.960
<v Speaker 1>Our team is Kristin Amyot, Tiffany Dimak, Jasper Leek, Lead,

0:12:43.000 --> 0:12:46.920
<v Speaker 1>Sam mcglou, Joshua Burton, Stephanie Coombs and me Claire Harvey.